Parkinson’s Disease / 2015 / Article / Tab 2

Clinical Study

Self-Reported Executive Functioning in Everyday Life in Parkinson’s Disease after Three Months of Subthalamic Deep Brain Stimulation

Table 2

Results of neurological measurements; Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS-III) motor scores, Hoehn and Yahr disease stage, and levodopa equivalent daily dose (LEDD) in mg preoperatively and at 3-month follow-up.

Mean (SD)
3-months follow-up
Mean (SD)
Mean differences

MDS-UPDRS III Off, mean (SD)48.9 (12.4)19.8 (9.7)29.1 (10.7)<0.001
MDS-UPDRS III On, mean (SD)15.9 (9.4)12.2 (7.8)3.7 (9.0)0.014
Hoehn and Yahr Off, mean (range)3.1 (2–4)2.2 (1–3)0.9 (0.6)<0.001
Hoehn and Yahr On, mean (range)1.9 (0–3)1.8 (0–3)0.1 (0.5)0.152
LEDD in mg, mean (SD)1217 (433)636 (327)581 (368)<0.001

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.